Abbott Laboratories (ABT) Price to FCF (2009 - 2026)

Abbott Laboratories has disclosed Price to FCF across 18 years of filings, most recently posting 78.86 for Q2 2026.

• In Q2 2026, Price to FCF fell 48.53% year-over-year to 78.86; the TTM figure through Jun 2026 stood at 20.07 (down 42.56% YoY), while the FY2025 annual figure was 29.44, down 4.69% from the prior year.
• Price to FCF came in at 78.86 for Q2 2026 at Abbott Laboratories, down from 195.23 in the prior quarter.
• In the past five years, Price to FCF ranged from a high of 315.35 in Q1 2024 to a low of 72.94 in Q3 2022.
• Average Price to FCF over 5 years is 144.18, with a median of 115.01 recorded in 2022.
• Year-over-year, Price to FCF surged 190.15% in 2023 and tumbled 53.39% in 2024.
• Over 5 years, Price to FCF stood at 111.19 in 2022, then declined by 24.76% to 83.66 in 2023, then climbed by 9.17% to 91.33 in 2024, then fell by 9.22% to 82.91 in 2025, then declined by 4.88% to 78.86 in 2026.
• Per Business Quant data, the three most recent Price to FCF figures were 78.86 in Q2 2026, 195.23 in Q1 2026, and 82.91 in Q4 2025.